Remicade Drug Market 2028 By Product Type, Application | The Insight Partners

report image

Remicade Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type ( Branded Drugs, Generic Drugs ); Application ( Crohn's Disease, Pediatric Crohn's Disease, Ulcerative Colitis, Pediatric Ulcerative Colitis, Other )

Report Code: TIPRE00019325 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Infliximab a monoclonal antibody is marketed as Remicade and is used to treat autoimmune diseases. It is used to treat conditions like ulcerative colitis, Crohn's disease, psoriasis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Behçet's disease. It binds to TNF-? thereby preventing autoimmune reaction.


The remicade drug market is driving due to the increasing research on treating autoimmune diseases and growing cases of many autoimmune diseases. Moreover, growing awareness for autoimmune diseases in developed as well as developing countries is likely to create growth opportunities in the market.


The "Remicade drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Remicade drug market with detailed market segmentation by product type and application. The remicade drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Remicade drug market and offers key trends and opportunities in the market.


The remicade drug market is segmented on the basis of product type, and application. Based on product type the market is segmented as branded drugs and generic drugs. The application segment is divided into crohn's disease, pediatric crohn's disease, ulcerative colitis, pediatric ulcerative colitis, and other.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the remicade drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The remicade drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting remicade drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the remicade drug market in these regions.

Get more information on this report :


The report covers key developments in the remicade drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from remicade drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for remicade drug in the global market. Below mentioned is the list of few companies engaged in the remicade drug market.

The report also includes the profiles of key players in remicade drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Merck And Co
  •   Celltrion Inc.
  •   NAPP Pharmaceuticals
  •   Janssen Biotech Inc
  •   PFIZER Inc
  •   Alvogen
  •   Nippon Kayaku
  •   Amgen Inc.
  •   Ranbaxy Laboratories
  •   Samsung Bioepis

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Merck And Co
2. Celltrion Inc.
3. NAPP Pharmaceuticals
4. Janssen Biotech Inc
6. Alvogen
7. Nippon Kayaku
8. Amgen Inc.
9. Ranbaxy Laboratories
10. Samsung Bioepis
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount